Literature DB >> 35070626

Maternal resveratrol supplementation ameliorates bisphenol A-induced atherosclerotic lesions formation in adult offspring ApoE-/- mice.

Srinivasa Rao Sirasanagandla1, Isehaq Al-Huseini2, Mohamed Al Mushaiqri1, Nadia Al-Abri3, Fatma Al-Ghafri3.   

Abstract

Current evidence suggests that intrauterine bisphenol A (BPA) exposure increases the risk of developing cardiovascular diseases in later stages of life. The beneficial effect of resveratrol (Rsv) on developmental programming of atherosclerosis lesions formation in offspring is seldom reported. Hence, we sought to study the effect of maternal Rsv in ameliorating perinatal BPA exposure-induced atherosclerosis lesions formation in adult offspring using the apolipoprotein E-deficient (ApoE-/-) mice model. The pregnant ApoE-/- mice were allocated into three groups: control, BPA, BPA + resveratrol (BPA + Rsv). The BPA group mice received BPA in their drinking water (1 μg/ml). BPA + Rsv group mice received BPA in their drinking water (1 μg/ml) and were treated orally with Rsv (20 mg kg-1 day-1). All the treatments were continued throughout the gestation and lactation period. Quantitative analysis of Sudan IV-stained aorta revealed a significantly increased area of atherosclerotic lesions in both female (p < 0.01) and male adult offspring mice (p < 0.01) in the BPA group. Supplementation with Rsv significantly reduced the BPA-induced atherosclerotic lesion development in the female offspring mice (p < 0.05). Transmission electron microscopy revealed the presence of a significantly high incidence of autophagic endothelial, smooth muscle, and macrophage cells in the aorta of BPA-exposed mice. Rsv treatment reduced the incidence of autophagic cells in BPA-exposed mice. In conclusion, maternal Rsv supplementation significantly prevents the BPA-induced atherosclerotic lesions formation in a sex-dependent manner potentially by acting as an autophagy modulator. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-021-03078-y. © King Abdulaziz City for Science and Technology 2022.

Entities:  

Keywords:  Atherosclerosis; Autophagy; Bisphenol A; Pregnancy; Resveratrol

Year:  2022        PMID: 35070626      PMCID: PMC8727657          DOI: 10.1007/s13205-021-03078-y

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  68 in total

Review 1.  The developmental origins of adult disease.

Authors:  Peter D Gluckman; Mark A Hanson; Catherine Pinal
Journal:  Matern Child Nutr       Date:  2005-07       Impact factor: 3.092

2.  Macrophage autophagy plays a protective role in advanced atherosclerosis.

Authors:  Xianghai Liao; Judith C Sluimer; Ying Wang; Manikandan Subramanian; Kristy Brown; J Scott Pattison; Jeffrey Robbins; Jennifer Martinez; Ira Tabas
Journal:  Cell Metab       Date:  2012-03-22       Impact factor: 27.287

3.  Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet.

Authors:  Amin Shah; Laura M Reyes; Jude S Morton; David Fung; Jillian Schneider; Sandra T Davidge
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

Review 4.  Bisphenol A, Hypertension, and Cardiovascular Diseases: Epidemiological, Laboratory, and Clinical Trial Evidence.

Authors:  Changwoo Han; Yun-Chul Hong
Journal:  Curr Hypertens Rep       Date:  2016-02       Impact factor: 5.369

5.  Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.

Authors:  C Napoli; F P D'Armiento; F P Mancini; A Postiglione; J L Witztum; G Palumbo; W Palinski
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation.

Authors:  Brittany M Angle; Rylee Phuong Do; Davide Ponzi; Richard W Stahlhut; Bertram E Drury; Susan C Nagel; Wade V Welshons; Cynthia L Besch-Williford; Paola Palanza; Stefano Parmigiani; Frederick S vom Saal; Julia A Taylor
Journal:  Reprod Toxicol       Date:  2013-07-25       Impact factor: 3.143

7.  Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice.

Authors:  Joji Miyawaki; Kenshi Sakayama; Hideo Kato; Haruyasu Yamamoto; Hiroshi Masuno
Journal:  J Atheroscler Thromb       Date:  2007-10-12       Impact factor: 4.928

8.  Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice.

Authors:  Thiago M Batista; Paloma Alonso-Magdalena; Elaine Vieira; Maria Esmeria C Amaral; Christopher R Cederroth; Serge Nef; Ivan Quesada; Everardo M Carneiro; Angel Nadal
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

Review 9.  Defective Autophagy in Atherosclerosis: To Die or to Senesce?

Authors:  Mandy O J Grootaert; Lynn Roth; Dorien M Schrijvers; Guido R Y De Meyer; Wim Martinet
Journal:  Oxid Med Cell Longev       Date:  2018-02-26       Impact factor: 6.543

10.  Aorta Atherosclerosis Lesion Analysis in Hyperlipidemic Mice.

Authors:  Sarajo Mohanta; Changjun Yin; Christian Weber; Desheng Hu; Andreas Jr Habenicht
Journal:  Bio Protoc       Date:  2016-06-05
View more
  2 in total

Review 1.  Natural Products in Mitigation of Bisphenol A Toxicity: Future Therapeutic Use.

Authors:  Srinivasa Rao Sirasanagandla; Isehaq Al-Huseini; Hussein Sakr; Marzie Moqadass; Srijit Das; Norsham Juliana; Izuddin Fahmy Abu
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

2.  Functional components of Chinese rice wine can ameliorate diabetic cardiomyopathy through the modulation of autophagy, apoptosis, gut microbiota, and metabolites.

Authors:  Jinjin Yang; Jiaoying Song; Jiedong Zhou; Hui Lin; Zhuonan Wu; Nan Liu; Wenqing Xie; Hangyuan Guo; Jufang Chi
Journal:  Front Cardiovasc Med       Date:  2022-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.